The digital therapeutics market is expected to showcase a remarkable growth rate during the forecast period at a global level. As per our report, the global digital therapeutics market size was estimated at USD 3.26 billion in 2021. This market is forecasted to grow USD 14.4 billion in 2026, registering a CAGR of 34.62% during the forecast period.
Digital therapeutics involves evidence-based therapeutic interventions for patients who use software to treat, monitor, and manage the disease. The constant up gradation in technology worldwide has increased awareness among the people about digital therapeutics' future possibilities.
MARKET DRIVERS:
Growing usage of smartphones and other smart devices is one of the significant growth drivers of the global digital therapeutics market.
These devices are connected with the help of the Internet and thus provides us with real-time data. Increasing government initiatives for preventive healthcare will further increase awareness among people and promote digital therapeutics. The entry of more companies into the market has led to more venture capital investments and has positively contributed to market growth. The user-friendliness and patient convenience factor of digital therapeutics are also significant advantages. The technological advancements in mobile healthcare are the key to the development of the global market.
The global digital therapeutics market growth is further expected to be driven by the factors such as the proliferation of chronic diseases, the constantly changing landscape, and technological advancements in the healthcare sectors across the world.
Digital therapeutics, on the other hand, are most likely to treat illnesses that are already underserved by the healthcare system, such as chronic illnesses or neurological disorders. Government programs for preventive healthcare, a substantial uptick in venture capital funding, and the advantages of digital therapeutics, such as the potential to elicit behavioral improvement, user-friendliness, patient comfort, and increased prescription enforcement, are all factors contributing to market development. End-user awareness is expected to rise due to digital devices and solutions, propelling the market forward. Furthermore, by reducing the pressures on doctors' resources, they will also provide care at a lower cost than conventional therapy.
Meanwhile, further data demonstrating their therapeutic utility continues to emerge. Consumer attitudes toward digital wellbeing are expected to continue to change, as is their demand for affordable, tailored, and engaging medical solutions. Over the years, in emerging countries, the growing demand for smartphones and internet usage is another significant technological driver for digital therapeutics.
The recent global pandemic of COVID-19 had a considerable influence on the digital therapeutics market.
The rise of demand for easy and affordable digital health solutions is the key COVID-related driver for the market. COVID-19 has stimulated the development of the medical and healthcare industries by providing them with the ability to introduce new products to the market. Increasing investments by the government and private organizations are more likely to encourage the digital therapeutic market.
MARKET RESTRAINTS:
The significant restriction for the global digital therapeutics market is the lack of digital therapeutics programs in developing countries.
The lack of access to proper technology has led to low awareness among people about the benefits of these programs and has hindered the market's growth. The main concern regarding this market is the patient data privacy concerns and unstable payment models, which remains a significant challenge for the development of this market. Resistance from traditional healthcare providers is going to affect market growth during the forecast period negatively.
Additionally, factors such as inadequate payment systems, resistance from traditional healthcare providers, and patient data privacy concerns present challenges to the market's development. A lack of awareness and access to digital therapeutics programs is expected to impede market growth. The market growth is restrained by the unfavorable regulatory framework and reimbursement policies.
Impact of COVID-19 on the global digital therapeutics market:
COVID-19 has positively impacted the global digital therapeutics market and will increase the projected growth rate. The coronavirus is spread by touch or when the infected person comes near an average person. Digital therapeutics allow us to treat, manage, and monitor the disease at any place without getting in contact with other people. The hospitals in significant areas have been prepared to deal with the current pandemic, and thus less priority is being given to people infected with other diseases. In these types of cases, digital therapeutics become very useful. The increase in smartphone usage during the pandemic will undoubtedly help the market grow during this time.
REPORT COVERAGE:
|
REPORT METRIC |
DETAILS |
|
Market Size Available |
2020 to 2026 |
|
Base Year |
2020 |
|
Forecast Period |
2021 to 2026 |
|
Segments Covered |
By product, sales channel, application, and region |
|
Various Analyses Covered |
Global, Regional & Country Level Analysis, Segment-Level Analysis, Drivers, Restraints, Opportunities, Challenges, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities |
|
Regions Covered |
North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
This market research report on the global digital therapeutics market has been segmented based on the product, sales channel, application, and region.
Digital Therapeutics Market - By Product:
Based on the product, the software segment is estimated to lead the digital therapeutics market during the forecast period. The rise in the software companies' support to reduce healthcare costs worldwide fuel the demand for this segment. Increasing incidences of obesity-related problems and growing awareness to maintain a healthy diet and launch different smartphones significantly increase the need for the software segment in this space.
However, the devices segment is expected to grow at a healthy rate during the future forecast period. Digital therapeutics provides the health or social care interventions delivered through a smart device for supporting healthy behaviors. It also offers therapeutic effects for treating type II diabetes, Alzheimer’s disease, dementia, congestive heart failure, chronic obstructive pulmonary disease, asthma, and other disorders. There is a rise in the research and development activities for devices related to digital therapeutics. For instance, in February 2019, Cognoa had received the Breakthrough Device Designation from the Food and Drug Administration (FDA) for the digital diagnostic and digital therapeutic devices for autism. These devices would help in earlier identification and treatment of pediatric behavioral health conditions.
Digital Therapeutics Market - By Sales Channel:
Based on the sales channel, the B2B sub-segment had the largest market share in 2019 and is expected to grow at the highest rate during the forecast period. The B2B segment is further subdivided into Providers, Payers, Employers, Pharmaceutical companies, and others. The main reason behind the increasing growth rate of this sub-segment is growing awareness among providers, payers, and employers about the benefits provided by digital therapeutics. The cost reductions achieved by B2B are another positive factor for the market. The growing inclination of pharmaceutical companies to combine digital therapeutics with drug products to improve their sales will further propel the market's growth.
B2C sub-segment is expected to grow at a prominent rate in the future. It is further sub-segmented into patients and caregivers. The caregiver's sub-segment is expected to dominate in terms of revenue and growth rate during the forecast period. The initiatives carried out by pharmaceutical companies to develop their product and promote it using digital therapeutics is the main positive contributing factor.
Digital Therapeutics Market - By Application:
Based on the application, Diabetes is expected to grow with the fastest growth rate during the forecast period and had a significant market share in 2020. Diabetes causes a substantial disease burden and despondence among patients who acquire the disease. The prevalence of unhealthy lifestyles people causes diabetes. Patients who have diabetes require effective management coaching to handle symptoms like polyuria, polydipsia, and polyphagia. The advancement in technology will further increase mobile health applications as the cases of diabetes are increased.
Obesity is expected to grow at a healthy rate during the forecast period. The increasing prevalence of unhealthy lifestyles among people is the leading cause of obesity.
Digital Therapeutics Market - By Region:
Geographically, the North American digital therapeutics market dominated the global market in 2019 and is expected to grow at a healthy rate during the forecast period. The growing demand has led to the entry of new players, and their combination with old players to provide better service has helped the market grow. The development of healthcare services will fuel the growth of the market.
The European digital therapeutics market had the second-largest market in 2019 and grew at a reasonable rate in the future. The rising number of diseases due to the increasing population and unhealthy lifestyle is the main contributing factor. The improvement in healthcare facilities will further improve the market.
The digital therapeutics market in the Asia Pacific region is expected to witness the highest growth rate in the future. The increase in population in countries like India and China is the main factor responsible for the high growth rate. The increased usage of smartphones and smart devices will further increase the growth of the market.
KEY MARKET PLAYERS:
Notable companies leading the global digital therapeutics market profiled in this report are 2Morrow, Inc., Pear Therapeutics, Inc., Fitbit, Inc. (Twine Health, Inc.), Proteus Digital Health, Inc., Livongo Health, Inc., Resmed, Inc. (Propeller Health), Voluntis, Inc., Omada Health, Inc. and Welldoc, Inc., and Medtronic Plc.
The report study will analyze the revenue impact of the COVID-19 pandemic on the sales revenue of market leaders, market followers, and disrupters in the report. The same is reflected in the analysis.
RECENT HAPPENINGS IN THIS DIGITAL THERAPEUTICS MARKET:
Related Reports
